chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning an 16 year old female who on 12-JUL-1994 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 19-MAY-1997, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 09-DEC-2009, the patient experienced mumps (diagnosed date reported as 30-DEC-2009). The patient was afebrile and had left side parotitis. The patient was reported as being exposed to mumps. On 30-DEC-2009, the IgM was <1.1 the IgG was 6.92 and serum amylase was 282. The outcome of the mumps was not reported. Follow up information has been received concerning the 16 year old male patient who on 12-JUL-1994 and on 19-MAY-1997 was vaccinated with the first and second doses of MMR II (route and lot # unknown), respectively. On 19-NOV-2009 the patient experienced mumps (he was diagnosed on 20-NOV-2009). The patient was afebrile and had L parotitis. On 20-NOV-2009, an IgM, and IgG and a serum amylase test were performed and results were 0.34, 3.81, and 176 respectively. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 15 year old female who on 30-MAY-1996 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported) HSA. On 02-APR-1998, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported) HSA. On 30-NOV-2009, the patient experienced mumps (diagnosed date reported as 16-NOV-2009). The patient was afebrile and had parotitis. On 16-NOV-2009, the patient's lab results were serum IgM was negative, serum IgG was 8.99 and serum amylase was 112. The outcome of the mumps was not reported. Follow-up information was received from the physician reporting that the patient experienced mumps on 18-NOV-2009 (previously reported as 30-NOV-2010) and was diagnosed on 20-NOV-2009 (previously reported as 16-NOV-2009). The patient had right parotitis. On 20-NOV-2009, the patient's lab results were serum IgM was less than 1:10, serum IgG was 7.36 and serum amylase was 188. The outcome of the mumps were not reported. No further information is available.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature increased, Diarrhoea
Clinical narrative: Information has been received from a physician concerning a 19 year old female who on 10-JUN-1991 (also reported on 10-JUN-1997) and 03-DEC-1997 was vaccinated with the first and second doses of MMR II (LOT# not reported), respectively. On 24-NOV-2009 the patient experienced onset of mumps. Mumps diagnosis reported as 10-NOV-2009. The patient also experienced headache, fever of 102F and diarrhea twice a day. On 10-NOV-2009, the patient had blood work was done that revealed IgM was 1:10:10, IgG was 0.72 and serum amylase was 204. The patient's outcome was unknown. Follow-up information has been received from a physician concerning the 19 year old female patient who on 02-DEC-2009 had blood work done that revealed IgM was 0.34, IgG was 5.69 and serum amylase was 66. On 12-JAN-2010, blood work was done that revealed IgM was <1:10, IgG was 4.91 and serum amylase was 172; and on 22-JAN-2010, blood work was done that revealed IgM was <1:10, IgG was 6.45 and serum amylase was 245. At the time of the report, the patient's status was unknown. Follow-up information has been received from a physician concerning the 19 year old female patient who on 01-DEC-2009 (previously reported as 24-NOV-2009) experienced onset of symptoms. On 02-DEC-2009 (previously reported as 10-NOV-2009), the patient was diagnosed with mumps. The patient was afebrile and had right parotitis. On 11-JAN-2010 the patient experienced onset of symptoms. On 12-JAN-2010, the patient was diagnosed with mumps. The patient was afebrile, had right parotitis and history mumps exposure in school. On 20-JAN-2010 the patient experienced onset of symptoms. On 22-JAN-2010, the patient was diagnosed with mumps. The patient was swelling under right ear and had right parotitis. At the time of report, the patient's status was unknown. No further information is available.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Exposure to communicable disease, Headache, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 19 year old female who on 10-JUN-1991 (also reported on 10-JUN-1997) and 03-DEC-1997 was vaccinated with the first and second doses of MMR II (LOT# not reported), respectively. On 24-NOV-2009 the patient experienced onset of mumps. Mumps diagnosis reported as 10-NOV-2009. The patient also experienced headache, fever of 102F and diarrhea twice a day. On 10-NOV-2009, the patient had blood work was done that revealed IgM was 1:10:10, IgG was 0.72 and serum amylase was 204. The patient's outcome was unknown. Follow-up information has been received from a physician concerning the 19 year old female patient who on 02-DEC-2009 had blood work done that revealed IgM was 0.34, IgG was 5.69 and serum amylase was 66. On 12-JAN-2010, blood work was done that revealed IgM was <1:10, IgG was 4.91 and serum amylase was 172; and on 22-JAN-2010, blood work was done that revealed IgM was <1:10, IgG was 6.45 and serum amylase was 245. At the time of the report, the patient's status was unknown. Follow-up information has been received from a physician concerning the 19 year old female patient who on 01-DEC-2009 (previously reported as 24-NOV-2009) experienced onset of symptoms. On 02-DEC-2009 (previously reported as 10-NOV-2009), the patient was diagnosed with mumps. The patient was afebrile and had right parotitis. On 11-JAN-2010 the patient experienced onset of symptoms. On 12-JAN-2010, the patient was diagnosed with mumps. The patient was afebrile, had right parotitis and history mumps exposure in school. On 20-JAN-2010 the patient experienced onset of symptoms. On 22-JAN-2010, the patient was diagnosed with mumps. The patient was swelling under right ear and had right parotitis. At the time of report, the patient's status was unknown. No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 17 year old male who on 19-MAY-1993 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 25-JUN-1997, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 10-NOV-2009, the patient experienced mumps (thought the date diagnosed was reported as 16-NOV-2009). On 16-NOV-2009 the patient had the following exams done: IgM (<1:10) negative, IgG (>1.10) 5.28, serum amylase 5.28. The patient was afebrile and had parotitis. At the time of the report the outcome for mumps was not reported. Follow up information has been received from the physician who reported that the 16 year old patient at symptoms onset date experienced mumps on 14-JAN-2010 (previously reported as 30-NOV-2009). The date diagnosed was reported as 15-JAN-2010 (previously reported as 16-NOV-2009). The patient had right parotitis. On 15-JAN-2010, the blood work test showed IgM <1:10, IgG 7.23 and serum amylase 69. At the time of the report the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Age: 1.04
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Initial and follow-up information has been received from a licensed practical nurse concerning a 12 month old female patient with no drug allergies and no medical history who at 11:50am on 24-JUN-2009 was vaccinated with the first dose of MMR II (lot number reported as 661687/0968X, a valid lot number for ROTATEQ) into the left lateral thigh. Secondary suspect vaccination administered at the same time on the same day included the first dose of VARIVAX (lot number 663819/0336Y) into the right thigh. Subsequently the patient experienced fever after vaccinations. Then the patient developed a rash approximately 10 days following the fever. The patient was not seen by the physician. No relevant diagnostic tests were performed. At the time of the report, the patient recovered from fever and rash. Additional information is not expected.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Local swelling, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 18 year old male who on 10-SEP-1992 was vaccinated with the first dose of MMR II.  On 14-OCT-1994, the patient was vaccinated with the second dose of MMR II.  On 09-NOV-2009 the patient experienced mumps.  It was diagnosed on 11-DEC-2009 that the patient had left parotitis.  The patient experienced no fever (also reported as afebrile).  The patient refused to take the first blood work.  At the time of this report, the patient's outcome was not reported.  Follow-up information was received from the physician indicating that on 25-NOV-2009, the 21 (previously reported a 18) year old patient developed mumps.  It was diagnosed on 29-NOV-2009 that the patient had right parotitis and swelling on left side of neck.  No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood test, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old male patient who on 07-AUG-1996 and 01-NOV-1998, was vaccinated with the first and second doses of MMR II, respectively. On 10-NOV-2009 the patient experienced mumps. On 29-NOV-2009, the patient was diagnosed. The patient was afebrile and had left parotitis. The parotitis count was 64. At the time of the report, the outcome was unknown. Follow up information was received which reported that on 29-DEC-2009 the patient experienced mumps again. On 31-DEC-2009, the patient was diagnosed. The patient was afebrile and had right parotitis. On 31-DEC-2009, the first blood work was performed (no result provided). At the time to the report, the outcome was unknown. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient who on 12-NOV-1997 and 14-MAR-2000 was vaccinated with the first and second doses of MMR II (HSA).  On 02-JAN-2010 the patient experienced mumps. On 03-JAN-2010, the patient was diagnosed with mumps. The parotitis was on the left side. The parotitis count was 48. At the time of this report the patients status was unknown. Follow up information from the physician indicated that the patient experienced mumps on 03-JAN-2010 (previously reported as 02-JAN-2010). On 04-JAN-2010 the patient was diagnosed with mumps. The patient was afebrile. On 04-JAN-2010, a first blood work was performed and showed that: IgM, <1:10; IgG, 9.25; serum amylase, 56. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Body temperature increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 19-MAR-1997 was vaccinated with the first dose of MMR II. On 07-JUL-1999 the patient received the second dose of MMR II. On 12-NOV-2009 the patient had a fever and his temperature was 100.5 F and experienced left parotitis. On 12-NOV-2009 laboratory test results showed IgM 1:10:00, IgG 5.42 and serum amylase 581. On 28-DEC-2009 the patient experienced mumps. At the time of the report, the outcome was unknown. Follow up information has been received concerning a 14 year old male who on 19-MAR-1997 was vaccinated with the first dose of MMR II. On 07-JUL-1999 the patient received the second dose of MMR II. On 01-DEC-2009 (previously reported as 28-DEC-2009) the patient experienced mumps. On 03-DEC-2009 the patient was afebrile and was diagnosed with mumps. The patient experienced left parotitis. Laboratory tests performed on 03-DEC-2009 showed IgM <1:10, IgG 7.22 and serum amylase 67. At the time of the report the outcome was unknown. No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 19-MAR-1997 was vaccinated with the first dose of MMR II. On 07-JUL-1999 the patient received the second dose of MMR II. On 12-NOV-2009 the patient had a fever and his temperature was 100.5 F and experienced left parotitis. On 12-NOV-2009 laboratory test results showed IgM 1:10:00, IgG 5.42 and serum amylase 581. On 28-DEC-2009 the patient experienced mumps. At the time of the report, the outcome was unknown. Follow up information has been received concerning a 14 year old male who on 19-MAR-1997 was vaccinated with the first dose of MMR II. On 07-JUL-1999 the patient received the second dose of MMR II. On 01-DEC-2009 (previously reported as 28-DEC-2009) the patient experienced mumps. On 03-DEC-2009 the patient was afebrile and was diagnosed with mumps. The patient experienced left parotitis. Laboratory tests performed on 03-DEC-2009 showed IgM <1:10, IgG 7.22 and serum amylase 67. At the time of the report the outcome was unknown. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old female patient who on 01-AUG-1996 and 15-OCT-1998 was vaccinated with the first and the second dose of MMR II. On 02-JAN-2010 the patient experienced mumps. The patient has no fever. The parotitis was on the right side. The parotitis count was 98. The date diagnosed was 12-NOV-2009. It was unknown if the patient had sought medical attention. The lab diagnostic tests performed: on 12-NOV-2009 IgM was negative, IgG was 4.6 and serum amylase was 195. At the time of report the patient's status was unknown. Follow-up information has been received from a physician concerning a 14 year old female patient on 29-DEC-2009 experienced mumps. The date diagnosed was 31-DEC-2009. The lab diagnostic tests performed: on 31-DEC-2009 IgM was <1:10, IgG was 5.65. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Exposure to communicable disease, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 11 year old female who on 26-FEB-1999 was vaccinated with the first dose of MMR II, and second dose (HSA) on 02-JUL-2002. On 13-DEC-2009 the patient developed mumps. She was diagnosed with mumps on 30-DEC-2009. The patient had parotitis, she did not have a fever. Blood works were performed on 30-DEC-2009. The serum immunoglobulin M test result was< 1:10. The serum immunoglobulin G was 6.93 and the serum amylase was 149. At the time of the report, the patient's outcome was unknown. Follow-up information has been received concerning the female patient who on 04-DEC-2009 experienced onset of symptoms. On 07-DEC-2009, the patient was diagnosed with mumps. The patient had a fever of 101 F degree and had right parotitis. On 07-DEC-2009, blood work was done and revealed that IgM was <1:10, IgG was 5.36 and serum amylase was 143. It was noted that the patient had exposure to others with mumps. At the time of the report, the patient's outcome was unknown. The AE onset date and blood work results have been updated. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 10 year old male who on 09-MAR-2000 and 03-SEP-2003 was vaccinated with the first and second doses of MMR II (LOT # not reported).  On 20-NOV-2009, the patient was diagnosed with mumps.  On 16-DEC-2009 the patient experienced mumps.  The patient was afebrile.  The blood work was done on 20-NOV-2009 and the results indicated IgM 0.34, IgG 3.81, and serum amylase 176.  The patient's outcome was unknown, this case was non-serious.  Follow-up information has been received from a physician concerning a 10 year old male who on 09-MAR-2000 and 03-SEP-2003 was vaccinated with the first and second doses of MMR II (LOT# not reported).  On 18-DEC-2009 the patient experienced mumps and on 20-DEC-2009 was diagnosed.  The patient had a parotitis.  The blood work results was not reported.  At the time of the report, the patient's outcome was unknown.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Orchitis, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old male patient who on 06-JAN-1998 was vaccinated with the first dose of MMR II. On 09-NOV-2000, the patient received the second dose of MMR II. On 04-DEC-2009, laboratory diagnostic tests were performed: IgG: 3.66; IgM 1:40:00 and serum amylase: 646. On 11-DEC-2009, the patient experienced mumps. The patient was afebrile and had parotitis. The outcome of the patient was not reported. Follow up information was received from a physician concerning a 13 year old (also reported as 12 year old) male patient who on 06-JAN-1998 was vaccinated with the first dose of MMR II (dose, route and lot number not reported). On 09-NOV-2000, the patient received the second dose of MMR II (dose, route and lot number not reported). The physician reported that the patient developed mumps on 18-JAN-2010 (previously reported). The physician reported that the patient developed mumps on 18-JAN-2010 (previously reported as 11-DEC-2009). This was diagnosed on 20-JAN-2010. Laboratory test performed on 20-JAN-2010 included IgM (0.55), IgG (6.64) and amylase (56). The patient had bilateral parotitis and it was unknown if the patient had orchitis. The patient did not experience any other symptoms. It was unknown if there were any sequelae. It was unknown if there was exposure to mumps. The third dose of MMR II was not given. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Injection site induration, Injection site urticaria, Injection site warmth, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a nurse practitioner concerning a 4 year old female patient with no pertinent medical history who on 29-DEC-2006 was vaccinated with the first dose of MMR II. It was reported that the patient did not have any reactions after the first vaccination. On 14-DEC-2009, the patient was vaccianted subcutaneousy with the second 0.5 ml dose of MMR II (Lot # 663508/1726X) into her right thigh. There was no concomitant medication. Within less than 1 minute after the second vaccination, there appeared a wheal. The wheal 20 minutes later was 1 inch,hard  and warm area. The patient was given BENADRYL (the nurse practitioner felt this was intervention to prevent serious criteria). No laboratory diagnostics studies were performed. At the time of the report, the patient was still in the office and had not recovered. The nurse practitioner felt that patient being given BENADRYL for the wheal was an other important medical event. Follow-up information has been received from a nurse practitioner concerning a 4 year old child on 14-DEC-2009 was vaccinated with the second dose of MMR II at 9:00 AM. With 1 minute after receiving the MMR II in her right thigh (also reported 09:09AM), she developed a 5mm wheal about 1 cm from the injection site. BENADRYL was given immediately. Over the next half an hour it progressed to 1 inch diameter, warm, indurated area, encompassing injection site. On the same day, this event was resolved in 2 hours. There was no illness at the time of vaccination. In follow-up, the nurse practitioner did not feel that administration of BENADRYL for the wheal was an other important medical event. No additional information is available.
Age: 19.0
Sex: M
Vaccine: MMR, TDAP
Symptoms: Cough, Oropharyngeal pain, Pyrexia, Rash generalised, Rash maculo-papular
Clinical narrative: Information has been received from a nurse practitioner concerning a 19 year old male patient who on 24-NOV-2009 was vaccinated with the first dose of MMR II. On 03-DEC-2009 the patient developed a fever (102F) and a rash after the first vaccination. The rash was a maculopapular rash. It was also reported that the MMR II was given in another facility. The patient spoke to the nurse practitioner for medical attention. On an unknown date, the patient had recovered. Follow up information has been received from the nurse practitioner concerning the male patient who on 24-NOV-2009 at 2:30 p.m. was vaccinated with a first SQ dose of MMR II (Lot # 664798/0773Y) in his left upper arm. Concomitant vaccination administered the same day at 2:30 p.m. included a first IM dose of ADACEL (Lot # UF45IDA) into his left deltoid. On approximately 03-DEC-2009, about 10 days after vaccination, the patient reported fever symptoms with sore throat, slight cough and congestion. On 07-DEC-2009 the patient was evaluated for generalized pruritic maculo-papular rash and had recovered from fever. At the time of the report, the patient had recovered. No further information is available.
Age: 19.0
Sex: M
Vaccine: MMR, TDAP
Symptoms: Rash pruritic, Respiratory tract congestion
Clinical narrative: Information has been received from a nurse practitioner concerning a 19 year old male patient who on 24-NOV-2009 was vaccinated with the first dose of MMR II. On 03-DEC-2009 the patient developed a fever (102F) and a rash after the first vaccination. The rash was a maculopapular rash. It was also reported that the MMR II was given in another facility. The patient spoke to the nurse practitioner for medical attention. On an unknown date, the patient had recovered. Follow up information has been received from the nurse practitioner concerning the male patient who on 24-NOV-2009 at 2:30 p.m. was vaccinated with a first SQ dose of MMR II (Lot # 664798/0773Y) in his left upper arm. Concomitant vaccination administered the same day at 2:30 p.m. included a first IM dose of ADACEL (Lot # UF45IDA) into his left deltoid. On approximately 03-DEC-2009, about 10 days after vaccination, the patient reported fever symptoms with sore throat, slight cough and congestion. On 07-DEC-2009 the patient was evaluated for generalized pruritic maculo-papular rash and had recovered from fever. At the time of the report, the patient had recovered. No further information is available.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a licensed practical nurse concerning a 10 year old male patient with seizure disorder and "mental delay" who on 31-MAY-2009 was vaccinated SQ with a 0.5 mL second dose of VARIVAX (Merck) (lot # 664021/0502Y).  Concomitant therapy included DILANTIN, TEGRETOL and clonidine (unspecified).  On 26-AUG-2009 the patient experienced redness and swelling at the injection site of the left upper arm.  The patient's parent called the office and was recommended to give the patient TYLENOL and to apply cool compresses.  No laboratory or diagnostic tests were performed.  The patient's symptoms resolved on 28-AUG-2009.  Additional information has been requested.
Age: 31.0
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity, Pharyngeal oedema
Clinical narrative: Information has been received from a 41 year old female patient who in "1999" was vaccinated with her first dose of MMR II (lot # not provided).  After getting the vaccine the patient experienced allergic reaction like throat swelling.  The patient had sought unspecified medical attention on an unspecified date.  The patient's allergic reaction like throat swelling improved.  The outcome of the patient's allergic reaction like throat swelling was not reported.  No further information is available.
Age: 0.94
Sex: U
Vaccine: MMR
Symptoms: Inappropriate schedule of drug administration, Injection site erythema, Injection site swelling, Medication error
Clinical narrative: Information has been received from a Registered Nurse concerning a 12 month old patient who on an unspecified date was vaccinated with the first dose of MMR II. It was reported that on an unspecified date following the vaccination the patient experienced redness and swelling. The outcome of the patient was not reported. Follow-up information was received from a Registered Nurse. In approximately October 2002 (based on patient's date of birth and age reported at vaccination), the patient was vaccinated with the first dose of MMR II and experienced swelling and redness after vaccination. This is one of several cases from the same source. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, No therapeutic response
Clinical narrative: Information has been received from a registered nurse concerning a 27 month old (now 26 year old) female with no known drug reactions/allergies and medical history, who in August 1983 received the first dose of MMR II (route and lot numbers not reported).  In August 1984, the patient was administered the second dose of MMR II.  The registered nurse stated that the patient had titers completed in 2007, the measles results were equivocal, the patient was given a third dose of MMR II (route and lot number not reported).  In March 2009 the patient's titers were equivocal.  The titers were repeated in April 2009, the patient was seronegative for measles.  The patient sought medical attention by follow up with the nurse.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Body temperature increased, Mumps, Oropharyngeal pain, Parotitis
Clinical narrative: Information has been received from a physician concerning a 9 year old male on 21-MAR-2001, and 29-JUL-2004 was vaccinated with the first and second dose of MMR II respectively (route, site, and lot number not reported). On 25-DEC-2009 the patient experienced mumps (the date diagnosed was reported as 18-NOV-2009). The patient also experienced sore throat and was afebrile. On 18-NOV-2009, the first blood work was done which revealed serum IgM <1:10, serum IgG 2.27, and serum amylase 352. The outcome for mumps was not reported. Follow up information has been received from the physician concerning the 9 year old (also reported as 7 year old) male patient who on 13-JAN-2010 developed and was diagnosed with mumps. The patient developed right parotitis. The patient's body temperature was 103 degrees F. On 13-JAN-2010, the first blood work was done which reveled serum IgM <1:10, serum IgG 6.22, and serum amylase 263. At the time of the report, the outcome of the patient was unknown. No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12 year old male on 16-FEB-1999 and 05-FEB-2001 was vaccinated with the first and second dose of MMR II, respectively (route, site, and lot number not reported). On 24-DEC-2009 the patient experienced mumps (the date diagnosed was reported as 30-NOV-2009). The patient also experienced parotitis and a fever of 100.6 degree F. On 30-NOV-2009, the first blood work was done which revealed serum IgM 13.29, serum IgG 0.26, and serum amylase 183. The outcome for mumps was not reported. Follow up information has been received from a physician concerning a 12 year old (also reported as 10 year old) male patient who on 12-DEC-2009 (date diagnosed was reported as 13-DEC-2009) experienced left parotitis. The patient was afebrile. On 14-DEC-2009 laboratories test revealed: serum immunoglobulin M test: < 1:10, serum immunoglobulin G test: 5.02 and serum amylase test: 111. The outcome for mumps was not reported. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Orchitis, Pain in jaw, Parotitis
Clinical narrative: Information has been received from a physician concerning an 8 year old male on 08-JAN-2002 and 16-JUL-2005 was vaccinated with the first and second dose of MMR respectively (route, site and lot number not reported). On 01-DEC-2009 the patient experienced mumps (the date diagnosed was reported as 19-NOV-2009). The patient also experienced parotitis and was afebrile. On 17-NOV-2009, the first blood work was done which revealed serum IgM negative, serum IgG 4.41, and serum amylase 88. On 07-DEC-2009, the second blood work was done which revealed serum IgM <1:10, serum IgG 9.27, and serum amylase 39. The outcome for mumps was not reported. Follow-up information was received which reported that the 8 year old patient (also reported as 5 year old on 06-DEC-2009 (previously reported as on 01-DEC-2009) experienced mumps and orchitis. The patient was diagnosed on 06-DEC-2009. The patient also experienced left jaw swelling and pain. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Swelling
Clinical narrative: Information has been received from a physician concerning an 8 year old male on 08-JAN-2002 and 16-JUL-2005 was vaccinated with the first and second dose of MMR respectively (route, site and lot number not reported). On 01-DEC-2009 the patient experienced mumps (the date diagnosed was reported as 19-NOV-2009). The patient also experienced parotitis and was afebrile. On 17-NOV-2009, the first blood work was done which revealed serum IgM negative, serum IgG 4.41, and serum amylase 88. On 07-DEC-2009, the second blood work was done which revealed serum IgM <1:10, serum IgG 9.27, and serum amylase 39. The outcome for mumps was not reported. Follow-up information was received which reported that the 8 year old patient (also reported as 5 year old on 06-DEC-2009 (previously reported as on 01-DEC-2009) experienced mumps and orchitis. The patient was diagnosed on 06-DEC-2009. The patient also experienced left jaw swelling and pain. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Neck pain, Parotitis
Clinical narrative: Information has been received from a physician concerning a 11 year old male on 02-JUN-1999 and on 08-FEB-2002 was vaccinated with the first and second dose of MMR II respectively (route, site, and lot number not reported). On 27-NOV-2009 the patient experienced mumps (the date diagnosed was reported as 29-NOV-2009). The patient was afebrile. The outcome for mumps was not reported. Follow-up information was received which reported that the 11 year old (also reported as 10 year old) patient experienced mumps on 19-JAN-2010 (previously reported as 27-NOV-2009). The patient was diagnosed on 21-JAN-2010. The patient had pain under left ear and left side parotitis. On 21-JAN-2010, the first blood work was done which revealed serum IgM 0.41, serum IgG 4.45 and serum amylase 94. The outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Body temperature increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 19 year old male who on 27-FEB-1991 was vaccinated with a first dose of MMR II, site and lot number not reported. On 28-DEC-1998, the patient was vaccinated with a second dose of MMR II (route, site and lot number not reported. On 29-NOV-2009, the patient experienced mumps (date diagnosed reported as 24-DEC-2009). The patient had right parotitis and fever of 100.2 degrees F. The outcome for mumps was not reported. Follow up information has been received from the physician who reported that the patient experienced mumps on 11-NOV-2009 (also reported by the physician as: 24-DEC-2009). The patient had parotitis (also reported by physician as: right parotitis) and the patient was afebrile (also reported by physician as the patient had fever of 100.2 degrees F). On 13-NOV-2009 a laboratory blood work were performed and the results showed: serum immunoglobulin M test (Ig M) negative, serum amylase test: 567, serum immunoglobulin G test: 4. The outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin M, Body temperature increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 18 year old female who on 27-AUG-1992 was vaccinated with the first dose of MMR II, and the second dose on 14-OCT-1994. On 24-DEC-2009 the patient developed mumps. Date of mumps diagnosis reported as 03-DEC-2009. The patient had a fever of 102F and left parotitis. On 03-DEC-2009, blood work was performed (results not reported). At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician. It was reported that on 28-DEC-2009 (previously reported as 24-DEC-2009) the patient developed mumps. Date of mumps diagnosis reported as 30-NOV-2009 (previously reported as 03-DEC-2009). The patient had a fever of 100.6F and right parotitis (previously reported as left parotitis). At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician. On 30-NOV-2009, the first blood work was performed: serum mumps immunoglobulin M antibody 13.29; serum mumps immunoglobulin G antibody 0.26 and serum amylase 183. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning an 18 year old female who on 27-AUG-1992 was vaccinated with the first dose of MMR II, and the second dose on 14-OCT-1994. On 24-DEC-2009 the patient developed mumps. Date of mumps diagnosis reported as 03-DEC-2009. The patient had a fever of 102F and left parotitis. On 03-DEC-2009, blood work was performed (results not reported). At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician. It was reported that on 28-DEC-2009 (previously reported as 24-DEC-2009) the patient developed mumps. Date of mumps diagnosis reported as 30-NOV-2009 (previously reported as 03-DEC-2009). The patient had a fever of 100.6F and right parotitis (previously reported as left parotitis). At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician. On 30-NOV-2009, the first blood work was performed: serum mumps immunoglobulin M antibody 13.29; serum mumps immunoglobulin G antibody 0.26 and serum amylase 183. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Rash generalised, Rash papular
Clinical narrative: Information has been received from a physician concerning a around 25 year old female with drug allergy of TYLENOL and ibuprofen and with no other pertinent medical history who in January 2010, was vaccinated with a dose of MMR II post partum. In January 2010, 7 days post vaccination, the patient developed generalized papular rash. No labs were performed. The patient's generalized papular rash persisted. The patient sought medical attention by calling the physician. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 8 year old male who on 01-JAN-2004 and 14-JUN-2006 was vaccinated with first and second doses of MMR II (lot# not reported). On 01-JAN-2010 the patient experienced parotitis. At the time of the report, the patient's outcome was unknown. Follow up information has been received from the physician who reported that the 8 year old patient (also reported as 9 year old at onset date) experienced mumps on 16-JAN-2010. The date diagnosed was reported as 17-JAN-2010. The patient had left parotitis. On 17-JAN-2010, the blood work test showed IgM <1:10, IgG 7.7 and serum amylase 606. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information was received from a physician concerning an 18 (also reported as 8) year old male who on 06-AUG-2002 was vaccinated with the first dose of MMR II (HSA) (lot number not reported) and on 15-MAY-2007 was vaccinated with second dose of MMR II (HSA) (lot number not reported). The patient was fever at 102. On 23-NOV-2009, lab result revealed that IgM <1:10, IgG 5.17 and serum amylase 86. On the same date, the patient diagnosed as parotitis. On 06-DEC-2009 the patient experienced mumps. Follow-up information was received which reported that the 18 (also reported as 17) year old patient on 10-JAN-2010 developed mumps. The patient was afebrile. No laboratory tests were conducted. At the time of the report, the patient's status was unknown. No further information is available.
Age: 9.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Laboratory test, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 18 year old male who on 14-OCT-1994 and 21-FEB-2001 was vaccinated with the first and the second doses of MMR II respectively. On 09-NOV-2009 the patient experienced mumps. On 26-NOV-2009, the patient was diagnosed and the patient was afebrile. The patient had left parotitis. The parotitis count was 83. At the time of the report, the outcome of the patient was unknown. Follow up information has been received from a physician reported that on 09-JAN-2010 (also reported as 09-NOV-2009) the 18 year old (also reported as 12 year old) patient experienced mumps. On 10-JAN-2010 (also reported as 26-NOV-2009) the patient was diagnosed and the patient's body temperature was 102.8 degree Fahrenheit (also reported as afebrile). It was reported that the patient was exposed to others with mumps 2 weeks ago. This is one of several reports from the same source. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 11 year old female who on an unspecified date, was vaccinated with a dose of MMR II. On 02-NOV-2009 the patient experienced mumps. On 01-DEC-2009, the patient was diagnosed and the patient was afebrile. The patient had parotitis. Parotitis count was 139. At the time of the report, the outcome of the patient was unknown. Follow up information has been received from a physician reported that on 09-NOV-2009 the patient experience mumps. On 11-NOV-2009 the patient was diagnosed. The patient had right parotitis. On the same day, the first blood work was performed and no result was provided. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature normal, Exposure to communicable disease, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 11 year old female who on 13-SEP-1999 was vaccinated with the first dose of MMR II (route, site, dose and lot number not reported), and on 02-JUL-2002 received the second dose of MMR II (route, site, dose and lot number not reported). On 06-DEC-2009 the patient experienced mumps (thought the date diagnosed was reported as 12-NOV-2009). The patient was afebrile. The labs showed serum mumps immunoglobulin M antibody test negative, serum mumps immunoglobulin G antibody test 1.2 and serum amylase test 39. Follow up information has been received concerning the 11 year old female patient who on 13-SEP-1999 and on 02-JUL-2002 was vaccinated with the first and second dose of MMR II (route and lot # unknown), respectively. On 09-JAN-2010, the patient experienced mumps (she was diagnosed on 13-JAN-2010). The patient had R parotitis. It was reported that there was unspecified exposure to others with mumps. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis, Swelling face
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 07-DEC-1996 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 03-MAY-2000, the patient was vaccinated with as second dose of MMR II (route, site, dose and lot number not reported). On 01-DEC-2009 the patient experienced mumps. (thought the date diagnosed was reported as 31-DEC-2009). The patient was afebrile. The outcome for mumps was not reported. Follow up information was received from a physician who reported that the patient was 14 year old who on 20-JAN-2010, experienced mumps. ON 21-JAN-2010, the patient was diagnosed with swollen left cheek and left parotitis. It was unknown if patient had orchitis. The patient had no other symptoms. The first work was performed on 21-JAN-2010 and the results were: IgM: <1:10; IgG: 5.32 and serum amylase: 189. The patient was diagnosed with mumps on 21-JAN-2010. This is one of several reports from the same source. No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 18 year old male patient who on 18-NOV-1992 and 01-JUL-1997 was vaccinated with the first and the second dose of MMR II. On 11-NOV-2009 the patient experienced mumps. The patient had no fever. The parotitis was on the both sides. The parotitis count was 6. The date diagnosed was 17-NOV-2009. It was unknown if the patient had sought medical attention. The lab diagnostic tests performed: On 17-NOV-2009 IgM was negative, IgG was 2.94 and serum amylase was 478. At the time of report the patient's status was unknown. Follow-up information has been received from a physician indicated that the 16 year old male patient was on 28-NOV-2009 experienced mumps. The date diagnosed was 30-NOV-2009. The parotitis was on the right side. The date of first blood work was 30-NOV-2009. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature normal, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 16 year old female who on 28-OCT-1996 was vaccinated with a first dose of MMR II HSA (route, site, dose and lot number not reported). On 24-SEP-1997, the patient was vaccinated with a second dose of MMR II HSA (route, site, dose and lot number not reported). On 22-NOV-2009 the patient experienced mumps. Mumps was diagnosed on 12-NOV-2009. The patient was afebrile. The outcome for mumps was not reported. Follow up information has been received reporting that the patient who was vaccinated with first and second dose of MMR II HSA (route, site, dose and lot number not reported) on 26-OCT-1995 (previously reported as 28-OCT-1996) and on 24-SEP-1997 respectively. On 02-JAN-2010 (previously reported as 22-NOV-2009) the patient experienced mumps. Mumps was diagnosed on 03-JAN-2010 (previously reported as 12-NOV-2009). The patient was afebrile and had right parotitis. At the time of the report the patient's outcome was unspecified. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 16 year old male who on 18-OCT-1994 was vaccinated with the first dose of MMR II (HSA). On 02-SEP-1997 the patient received the second dose of MMR II (HSA). On 12-DEC-2009 the patient experienced mumps. On 28-DEC-2009 the patient was diagnosed with parotitis. The temperature was 103 F, the patient had a fever and laboratory test results showed IgM <1:10, IgG 5.87 and serum amylase 267. At the time of the report, the outcome was unknown. Follow up information has been received concerning a 16 year old (also reported as 15 year old male who on 18-OCT-1994 was vaccinated with the first dose of MMR III (HSA).  On 02-SEP-1997 the patient received the second dose of MMR II (HSA). On 30-NOV-2009 (previously reported as 12-DEC-2009) the patient experienced mumps. On 02-DEC-2009 the patient was afebrile and was diagnosed with mumps. The patient had right parotitis. Laboratory test results showed IgM <1:10, IgG 1.73 and serum amylase 50. At the time of the report, the outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 16 year old male who on 18-OCT-1994 was vaccinated with the first dose of MMR II (HSA). On 02-SEP-1997 the patient received the second dose of MMR II (HSA). On 12-DEC-2009 the patient experienced mumps. On 28-DEC-2009 the patient was diagnosed with parotitis. The temperature was 103 F, the patient had a fever and laboratory test results showed IgM <1:10, IgG 5.87 and serum amylase 267. At the time of the report, the outcome was unknown. Follow up information has been received concerning a 16 year old (also reported as 15 year old male who on 18-OCT-1994 was vaccinated with the first dose of MMR III (HSA).  On 02-SEP-1997 the patient received the second dose of MMR II (HSA). On 30-NOV-2009 (previously reported as 12-DEC-2009) the patient experienced mumps. On 02-DEC-2009 the patient was afebrile and was diagnosed with mumps. The patient had right parotitis. Laboratory test results showed IgM <1:10, IgG 1.73 and serum amylase 50. At the time of the report, the outcome was unknown. No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature normal, Mumps
Clinical narrative: Information has been received from a physician concerning an 18 year old male who on 08-FEB-1993 was vaccinated with the first dose of MMR II (route, site and lot number not reported). On 21-JUL-1999, the patient was vaccinated with the second dose of MMR II (route, site and lot number not reported). On 30-NOV-2009 the patient experienced mumps (date diagnosed was reported as 03-DEC-2009). The patient was afebrile and had orchitis and body ache. On 03-DEC-2009, the laboratory tests showed serum amylase test 122, serum immunoglobulin G test 2.53 and serum immunoglobulin M test <1:10. The outcome for mumps was not reported. Follow up information has been received concerning the 18 year old male patient who on 11-JAN-2010 (previously reported as 30-NOV-2009) experienced mumps. On 14-JAN-2010 (previously reported as 03-DEC-2010), the patient was diagnosed with mumps. It was noted that the patient developed orchitis for three days. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Orchitis, Pain
Clinical narrative: Information has been received from a physician concerning an 18 year old male who on 08-FEB-1993 was vaccinated with the first dose of MMR II (route, site and lot number not reported). On 21-JUL-1999, the patient was vaccinated with the second dose of MMR II (route, site and lot number not reported). On 30-NOV-2009 the patient experienced mumps (date diagnosed was reported as 03-DEC-2009). The patient was afebrile and had orchitis and body ache. On 03-DEC-2009, the laboratory tests showed serum amylase test 122, serum immunoglobulin G test 2.53 and serum immunoglobulin M test <1:10. The outcome for mumps was not reported. Follow up information has been received concerning the 18 year old male patient who on 11-JAN-2010 (previously reported as 30-NOV-2009) experienced mumps. On 14-JAN-2010 (previously reported as 03-DEC-2010), the patient was diagnosed with mumps. It was noted that the patient developed orchitis for three days. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.